Neumora Therapeutics

NMRA · NASDAQ

$0.465−$0.005 (−1.06%)TodayMarket closed ·
Prev close $0.47

Who owns NMRA

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 61.7% of NMRA’s shares.

  • Amgen Inc19.1%
  • ARCH Venture Partners18.3%
  • Invus Public Equities Advisors, LLC4.6%
  • Berns (Paul L)4.2%
  • Next 6 largest institutions15.6%
  • All other shareholders38.3%
Top institutional holders of NMRA
HolderShares% of shares
Amgen Inc35.37M19.09%
ARCH Venture Partners33.85M18.27%
Invus Public Equities Advisors, LLC8.50M4.59%
Berns (Paul L)7.71M4.16%
BlackRock Institutional Trust Company, N.A.6.84M3.69%
SB Global Advisers Ltd6.09M3.29%
Vanguard Capital Management, LLC4.67M2.52%
MIC Capital Management UK LLP4.46M2.41%
Fidelity Management & Research Company LLC3.50M1.89%
Wellcome Trust3.31M1.79%

Largest mutual fund holders

Top mutual fund holders of NMRA
HolderShares% of shares
Vanguard Total Stock Market Index Fund3.44M1.85%
iShares Russell 2000 ETF2.49M1.35%
Vanguard Extended Market Index Fund1.13M0.61%
Fidelity Small Cap Index Fund1.12M0.60%
iShares Russell 2000 Growth ETF878.70K0.47%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $701.64K (11 trades) of NMRA on the open market, with no buys.

Latest NMRA insider transactions
InsiderTypeSharesValue
Aurora Daljit SinghOption exercise21.05K—
Aurora Daljit SinghOption exercise20.55K—
Aurora Daljit SinghSale21.05K$33.60K
Aurora Daljit SinghOption exercise21.05K$15.16K
Aurora Daljit SinghSale20.55K$32.78K
Aurora Daljit SinghOption exercise20.55K$14.80K
Milligan Michael LeeAward175.00K—
Pinto JoshuaAward500.00K—
Aurora Daljit SinghAward200.00K—
Aurora Daljit SinghOption exercise21.68K—

Short interest

Settled Sep 30, 2026

Shares short
6.69M
Days to cover
2.69
% of shares outstanding
3.61%
Average daily volume
2.49M
Change since last report
−4.1%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.